Telix Pharmaceuticals Ltd has released a press release.
Telix Pharmaceuticals: Half Yearly Report and Accounts
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Telix files Ph III trial for Kidney Cancer Imaging in Europe
- Collaboration on Renal Cancer Imaging for Japanese market
- Telix JV Entity Extends Contract with Endocyte to Include EU
- Telix receives $55m Overseas Finding
- Appendix 4C - June 2018 Quarter
Later from Telix Pharmaceuticals
- TLX receives ethics approval to commence Glioblastoma Study
- Telix completes acquisition of Atlab Pharma
- Strategic Collaboration Agreement with GenesisCare
- Cyclotek Manufacturing Partnership for Kidney Cancer Imaging
- Telix and ANMI Expand PSMA Imaging Partnership
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals